Clinical Trial Update: Liposomal Bupivacaine in Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating liposomal bupivacaine for postoperative pain relief after total knee arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Exparel (liposomal bupivacaine) (liposomal bupivacaine)

Snippet

Sponsor: Miller Orthopedic Specialists | Conditions: Pain, Postoperative, Arthroplasty, Replacement, Knee | Phase 4 | Status: WITHDRAWN